echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Seric Medical's novel baculovirus (COVID-19) antigen kit obtained EU CE certification

    Seric Medical's novel baculovirus (COVID-19) antigen kit obtained EU CE certification

    • Last Update: 2022-03-09
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On January 17, Saili Medical stated on the interactive platform that the new baculovirus (COVID-19) antigen kit (colloidal gold) independently developed by the company is highly sensitive to identify the N and N of the new coronavirus in nasopharyngeal secretions.
    S protein, the presence of the virus can be detected in the early stage of the patient's onset (window period), and the test result can be obtained in about 15 minutes
    .


    The product has obtained EU CE certification and can be sold in the EU market


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.